Form 4: Molina Healthcare Director Ronna Romney Acquires Shares Under Equity Incentive Plan

Director Ronna Romney acquired 161 shares of Molina Healthcare common stock on October 1, 2024, as part of the company's 2019 Equity Incentive Plan.

Summary

• Ronna Romney, a director of Molina Healthcare, Inc., acquired 161 shares of common stock on October 1, 2024.
• The acquisition was made under the company's 2019 Equity Incentive Plan.
• The shares were granted as part of the annual equity award for directors, with a quarterly grant value of $55,000.
• The price per share was $341.91, based on the closing price of Molina Healthcare's common stock on October 1, 2024.
• Following the transaction, Ronna Romney beneficially owns 17,294 shares indirectly through a trust.
• Jeff D. Barlow, acting as power of attorney for Ronna Romney, signed the Form 4 filing.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction (director stock acquisition) under an existing equity incentive plan. It indicates confidence from a board member, but doesn't contain any groundbreaking news.

Positives

• The equity incentive plan aligns director interests with shareholder value.
• The acquisition reflects a continued investment in the company by a board member.

Future Outlook

The document does not contain specific forward-looking statements regarding the company's future performance.

Industry Context

Director stock acquisitions are common in publicly traded companies as part of compensation packages to align the interests of directors with those of shareholders. This transaction is a routine part of Molina Healthcare's director compensation program.

Comparison to Industry Standards

• Director compensation packages, including equity grants, are standard practice among publicly traded healthcare companies.
• Companies like UnitedHealth Group, Anthem, and Cigna also utilize equity incentive plans for their directors.
• The value of equity grants can vary based on company size, performance, and industry benchmarks.

Stakeholder Impact

• The transaction has a minor positive impact on shareholder sentiment as it demonstrates director alignment with company performance.

Key Dates